| * Aecom ACM.N: Barclays cuts target price to $90 from $110 |
| * Agilon Health Inc AGL.N: Leerink Partners adjusts PT to $92 from $1 to reflect 1-for-25 reverse stock split |
| * Agilysys Inc. AGYS.O: Oppenheimer raises target price to $100 from $90 |
| * Agree Realty Corp. ADC.N: Barclays cuts target price to $84 from $86 |
| * Alnylam Pharmaceuticals Inc ALNY.O: Citigroup initiates coverage with buy rating; target price $380 |
| * Altimmune Inc ALT.O: H.C. Wainwright cuts target price to $20 from $25 |
| * American Homes 4 Rent AMH.N: UBS cuts target price to $32 from $33 |
| * American Tower Corp AMT.N: Bernstein raises to outperform from market perform |
| * Apollo APO.N: Argus Research cuts target price to $160 from $168 |
| * Applied Materials Inc AMAT.O: Argus Research raises target price to $500 from $420 |
| * Biofrontera Inc BFRI.O: Benchmark cuts to speculative buy from buy |
| * Biomarin Pharmaceutical Inc BMRN.O: Citigroup initiates coverage with buy rating; target price $75 |
| * Blackstone Secured Lending Fund BXSL.N: Truist Securities cuts target price to $26 from $30 |
| * Block Inc XYZ.N: Canaccord Genuity raises target price to $85 from $80 |
| * Bridgebio Pharma Inc BBIO.O: Citigroup initiates coverage with neutral rating; target price $82 |
| * Brunswick Corporation BC.N: Morgan Stanley raises target price to $86.00 from $82.00 |
| * Citius Pharmaceuticals Inc CTXR.O: H.C. Wainwright assumes coverage with buy rating; target price $4 |
| * Costco Wholesale Corp COST.O: Oppenheimer raises target price to $1160 from $1100 |
| * Crowdstrike Holdings Inc CRWD.O: Barclays raises target price to $650 from $550 |
| * Crowdstrike Holdings Inc CRWD.O: Truist Securities raises target price to $650 from $550 |
| * CSX Corp CSX.O: BofA Global Research raises price objective to $51 from $49 |
| * Cytokinetics Inc CYTK.O: Citigroup initiates coverage with buy rating; target price $99 |
| * Dominion Energy D.N: RBC raises target price to $72 from $66 |
| * Ecolab Inc ECL.N: Wells Fargo cuts target price to $260 from $285 |
| * elf Beauty Inc ELF.N: Piper Sandler cuts target price to $60 from $85 |
| * Elmet Group Co ELMT.O: Canaccord Genuity initiates coverage with buy rating |
| * Elmet Group Co ELMT.O: Canaccord Genuity initiates coverage with target price $20 |
| * F5 Inc FFIV.O: RBC raises target price to $425 from $375 |
| * Federal Realty Investment Trust FRT.N: Scotiabank raises target price to $128 from $118 |
| * Global Payments Inc GPN.N: Truist Securities cuts target price to $76 from $81 |
| * Gossamer Bio GOSS.O: Barclays cuts target price to $0.28 from $0.3 |
| * Hanover Insurance Group Inc THG.N: BMO cuts to market perform from outperform |
| * Hanover Insurance Group Inc THG.N: BMO raises target price to $203 from $194 |
| * Harley-Davidson Inc HOG.N: Morgan Stanley raises target price to $15.00 from $12.00 |
| * HCA Healthcare Inc HCA.N: JP Morgan cuts target price to $490 from $535 |
| * Huntsman HUN.N: Deutsche Bank raises target price to $15 from $14 |
| * Interface Inc TILE.O: Benchmark initiates coverage with buy rating; target price $36 |
| * Invitation Homes Inc INVH.N: UBS cuts target price to $32 from $35 |
| * Ionis Pharmaceuticals Inc IONS.O: Citigroup initiates coverage with buy rating |
| * Ionis Pharmaceuticals Inc IONS.O: Citigroup initiates coverage with target price $115 |
| * J.M. Smucker Co SJM.N: JP Morgan cuts target price to $120 from $130 |
| * James River Group Holdings Inc JRVR.O: UBS cuts target price to $4.75 from $8 |
| * James River Group Holdings Inc JRVR.O: UBS cuts to neutral from buy |
| * Karman Holdings Inc KRMN.N: Piper Sandler cuts target price to $114 from $127 |
| * Korro Bio Inc KRRO.O: H.C. Wainwright cuts target price to $15 from $20 |
| * Legence Corp LGN.O: Barclays raises target price to $60 from $45 |
| * Main Street Capital Corp MAIN.N: Truist Securities cuts target price to $53 from $60 |
| * Micron Technology Inc MU.O: Citigroup raises target price to $840 from $425 |
| * Micron Technology Inc MU.O: HSBC raises target price to $1,100 from $750 |
| * Micron Technology Inc MU.O: Mizuho raises target price to $800 from $740 |
| * Mongodb Inc MDB.O: BofA Global Research raises price objective to $375 from $350 |
| * Neonc Technologies Holdings Inc NTHI.O: Alliance Global Partners initiates coverage with buy rating |
| * Neonc Technologies Holdings Inc NTHI.O: Alliance Global Partners initiates coverage with target price $13 |
| * Nextera Energy Inc NEE.N: Morgan Stanley raises target price to $115.00 from $107.00 |
| * Nextpower NXT.O: Barclays raises target price to $142 from $123 |
| * Norwegian Cruise Line Holdings Ltd NCLH.N: UBS cuts target price to $17 from $22 |
| * Nvidia Corp NVDA.O: HSBC raises target price to $325 from $295 |
| * Onsemi ON.O: Mizuho raises target price to $130 from $120 |
| * Palo Alto Networks Inc PANW.O: Truist Securities raises target price to $275 from $200 |
| * Pilgrims Pride Corp PPC.O: UBS initiates coverage with neutral rating and PT $30 |
| * Plug Power Inc. PLUG.O: Wells Fargo raises target price to $2.5 from $2 |
| * Plug Power Inc. PLUG.O: Wells Fargo raises target price to $2.5 from $2 |
| * Polaris Inc. PII.N: Morgan Stanley cuts target price to $69.00 from $74.00 |
| * Progyny Inc PGNY.O: Canaccord Genuity raises target price to $30 from $19 |
| * Progyny Inc PGNY.O: Canaccord Genuity raises to buy from hold |
| * Rackspace Technology Inc RXT.O: UBS raises target price to $5 from $2 |
| * Rapport Therapeutics Inc RAPP.O: Truist Securities raises target price to $56 from $44 |
| * RBC Bearings Inc RBC.N: Truist Securities raises target price to $615 from $599 |
| * Regeneron Pharmaceuticals Inc REGN.O: Canaccord Genuity cuts PT to $875 from $1,057 |
| * Sandisk Corp SNDK.O: Citigroup raises target price to $2,025 from $1,300 |
| * Simon Property Group Inc SPG.N: Barclays raises target price to $212 from $201 |
| * Simon Property Group Inc SPG.N: Scotiabank raises target price to $206 from $192 |
| * Strategy MSTR.O: TD Cowen raises target price to $400 from $395 |
| * Tenable Holdings Inc TENB.O: Barclays raises target price to $27 from $21 |
| * Texas Instruments Inc TXN.O: Mizuho raises target price to $300 from $255 |
| * Veeco Instruments Inc VECO.O: Barclays raises target price to $55 from $30 |
| * Viatris Inc. VTRS.O: Barclays raises target price to $22 from $17 |
| * W.P. Carey Inc WPC.N: Barclays raises target price to $78 from $72 |
| * Wave Life Sciences Ltd. WVE.O: H.C. Wainwright cuts target price to $13 from $18 |
| * X-Energy Inc XE.O: JP Morgan initiates coverage with overweight rating; price target $38 |
| * X-Energy Inc XE.O: Morgan Stanley initiates coverage with overweight rating |
| * X-Energy Inc XE.O: Morgan Stanley initiates coverage with price target $41 |
| * X-Energy Inc XE.O: TD Cowen initiates coverage with buy rating; target price $35 |
| * X-Energy Inc XE.O: UBS initiates coverage with buy rating and target price $40 |
| * Yesway Inc YSWY.O: Barclays initiates coverage with overweight rating and target price $31 |
| * Yeti Holdings Inc YETI.N: UBS raises target price to $45 from $40 |
| * Zeta Global Holdings Corp ZETA.N: BofA Global Research reinstates coverage with buy rating |
| * Zeta Global Holdings Corp ZETA.N: BofA Global Research reinstates coverage with target price $24 |
| * Zoominfo Technologies Inc GTM.O: BofA Global Research reinstates coverage with target price $4 |
| * Zoominfo Technologies Inc GTM.O: BofA Global Research reinstates coverage with underperform rating |
